[Cognitive Function and Calcium. Hypertension treatment in consideration of dementia]

Junko Nishihira1, Takashi Tokashiki, Yusuke Ohya

  • 1Dept. of Cardiovascular Medicine, Nephrology and Neurology, University of the Ryukyus, Okinawa, Japan.

Clinical Calcium
|January 31, 2015
PubMed

Insights

Controlling hypertension in middle age may prevent dementia. Angiotensin receptor blockers show promise as the most effective antihypertensive drugs for dementia prevention, warranting further research.

Area of Science:

  • Neurology
  • Gerontology
  • Cardiology

Context:

  • Dementia prevalence is rising, posing a significant societal challenge.
  • Hypertension in middle age is a known risk factor for future dementia.
  • The impact of late-life hypertension on dementia development remains unclear.

Purpose:

  • To review the role of antihypertensive treatment in dementia prevention.
  • To identify the most effective antihypertensive drug class for preventing dementia.

Summary:

  • Antihypertensive treatment in middle age is crucial for dementia prevention.
  • While some treatments show promise, specific drug efficacy for dementia prevention is not well-established.
  • Network meta-analysis suggests angiotensin receptor blockers may be most effective.

Impact:

  • Highlights the importance of managing mid-life hypertension for cognitive health.
  • Identifies a potential therapeutic strategy for dementia prevention.
  • Calls for future clinical trials to establish definitive evidence for dementia prevention endpoints.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
1
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
730
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
916
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
2
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K